Delivery Order SPE2DB24D2100-SPE2DB25FBFTS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $99,073.02 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $90,084.87 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services to support federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $16,247.74. The order was competitively awarded without set-aside provisions and has an ultimate completion date of July 23, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,363.49 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with a completion date of August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a...
- The Defense Logistics Agency awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for Eliquis 2.5 mg tablets (60-count supply). This competitive award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price transaction with no set-aside designation. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $38,339.80 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a $25,993.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of July 30, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,846.57 for Eliquis 5 mg tablets (60-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed price, non-set-aside contract represents a direct purchase under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $11,072.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of September 4, 2025. This non-set-aside competitive award was issued to the vendor's Corporate Office location in Conshohocken, Pennsylvania, supporting federal pharmaceutical procurement needs for military and veteran healthcare systems. The delivery order is executed under AmerisourceBergen's larger...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFTSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $49,377.86 to AmerisourceBergen Drug Corp for 60-count bottles of Eliquis 5 mg tablets, with an ultimate completion date of August 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The parent IDC provides a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Eliquis is an anticoagulant medication commonly used in military and veteran healthcare settings for stroke prevention and treatment of blood clots, making this delivery order consistent with the broad pharmaceutical supply mission of the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.4k | 8/11/25 |